Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Uster

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|March 8, 2022
Optimized sampling to estimate vancomycin drug exposure: Comparison of pharmacometric and equation-based approaches in a simulation-estimation studyDavid W Uster, Sebastian G Wicha
Therapeutic Innovation & Regulatory Science|August 30, 2024
Insights into Early Interactions on Innovative Developments with European RegulatorsDavid W Uster, Valentina Cordo', Emmanuel Cormier, et al.
Therapeutic Drug Monitoring|March 31, 2022
Dosing for Personalized Prophylaxis in Hemophilia A Highly Varies on the Underlying Population Pharmacokinetic ModelsDavid W Uster, Pratima Chowdary, Anne Riddell, et al.
Pharmaceutical Research|April 12, 2022
A Machine Learning Approach to Predict Interdose Vancomycin ExposureMehdi Bououda, David W Uster, Egor Sidorov, et al.
British Journal of Clinical Pharmacology|October 14, 2022
Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipientsRanita Kirubakaran, David W Uster, Stefanie Hennig, et al.
Clinical Pharmacology and Therapeutics|September 30, 2020
A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case StudyDavid W Uster, Sophie L Stocker, Jane E Carland, et al.
International Journal of Antimicrobial Agents|March 28, 2022
Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK modelsAstrid Heus, David W Uster, Veerle Grootaert, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
CPT: Pharmacometrics & Systems Pharmacology|March 8, 2022
Optimized sampling to estimate vancomycin drug exposure: Comparison of pharmacometric and equation-based approaches in a simulation-estimation studyDavid W Uster, Sebastian G Wicha
Therapeutic Innovation & Regulatory Science|August 30, 2024
Insights into Early Interactions on Innovative Developments with European RegulatorsDavid W Uster, Valentina Cordo', Emmanuel Cormier, et al.
Therapeutic Drug Monitoring|March 31, 2022
Dosing for Personalized Prophylaxis in Hemophilia A Highly Varies on the Underlying Population Pharmacokinetic ModelsDavid W Uster, Pratima Chowdary, Anne Riddell, et al.
Pharmaceutical Research|April 12, 2022
A Machine Learning Approach to Predict Interdose Vancomycin ExposureMehdi Bououda, David W Uster, Egor Sidorov, et al.
British Journal of Clinical Pharmacology|October 14, 2022
Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipientsRanita Kirubakaran, David W Uster, Stefanie Hennig, et al.
Clinical Pharmacology and Therapeutics|September 30, 2020
A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case StudyDavid W Uster, Sophie L Stocker, Jane E Carland, et al.
International Journal of Antimicrobial Agents|March 28, 2022
Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK modelsAstrid Heus, David W Uster, Veerle Grootaert, et al.
Pageof 1